ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 331121 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 331121; 2) Community: the network communities that were significantly associated with the response to NSC 331121; 3) Molecule: the relationships between components within communities and NSC 331121; 4) MDR: the compounds that were significantly associated with the NSC 331121.

NSC Compound Enrichment Correlation
NSC 672472 Null 0.000572036815736153 0.55348793
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.000572036815736153 0.21810365
NSC 686561 Benzoic acid, 2-chloro-4-[[(2,5-dihydroxyphenyl)methyl]amino]-, isopropyl ester 0.000572036815736153 0.73934608
NSC 690271 ANTINEOPLASTIC-690271 0.000572036815736153 0.54967523
NSC 700203 Null 0.000572036815736153 0.49843527
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.000601164336889762 0.084068515
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.000601164336889762 0.53180202
NSC 625985 Null 0.000601164336889762 0.75125051
NSC 632877 Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) 0.000601164336889762 0.81305455
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.000601164336889762 0.76833715
Total:131  Current:6    [First] [Prev] [Next] [Last]